PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks

Journal of Proteome Research

Volumn 14, Issue 10, 2015, Pages 4332-4341

  Raaijmakers, Linsey M ^a,b   Giansanti, Piero ^a,b   Possik, Patricia A ^c   Mueller, Judith ^c   Peeper, Daniel S ^c   Heck, Albert J R ^a,b   Altelaar, A F Maarten ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

biological network analysis; computational proteomics; Cytoscape; phosphoproteomics; phosphosite centric dynamics; posttranslational modifications; signaling

Indexed keywords

PEPTIDE; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; PROTEOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL LINE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; COMPUTER GRAPHICS; GENE REGULATORY NETWORK; GENETICS; ISOLATION AND PURIFICATION; MELANOMA; METABOLISM; MOBILE APPLICATION; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; SKIN TUMOR; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

CELL LINE, TUMOR; COMPUTER GRAPHICS; GENE REGULATORY NETWORKS; HUMANS; MELANOMA; MOBILE APPLICATIONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; SKIN NEOPLASMS; TANDEM MASS SPECTROMETRY;

EID: 84942900679     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00529     Document Type: Article

References (47)

1. Zhang, H.; Zha, X.; Tan, Y.; Hornbeck, P. V.; Mastrangelo, A. J.; Alessi, D. R.; Polakiewicz, R. D.; Comb, M. J. Phosphoprotein Analysis Using Antibodies Broadly Reactive against Phosphorylated Motifs J. Biol. Chem. 2002, 277, 39379-39387 10.1074/jbc.M206399200
2. Dephoure, N.; Gould, K. L.; Gygi, S. P.; Kellogg, D. R. Mapping and Analysis of Phosphorylation Sites: A Quick Guide for Cell Biologists Mol. Biol. Cell 2013, 24, 535-542 10.1091/mbc.E12-09-0677
3. Gstaiger, M.; Aebersold, R. Applying Mass Spectrometry-Based Proteomics to Genetics, Genomics and Network Biology Nat. Rev. Genet. 2009, 10, 617-627 10.1038/nrg2633
4. Altelaar, a F. M.; Munoz, J.; Heck, A. J. R. Next-Generation Proteomics: Towards an Integrative View of Proteome Dynamics Nat. Rev. Genet. 2013, 14, 35-48 10.1038/nrg3356
5. Beltran, L.; Cutillas, P. R. Advances in Phosphopeptide Enrichment Techniques for Phosphoproteomics Amino Acids 2012, 43, 1009-1024 10.1007/s00726-012-1288-9
6. Lemeer, S.; Heck, A. J. The Phosphoproteomics Data Explosion Curr. Opin. Chem. Biol. 2009, 13, 414-420 10.1016/j.cbpa.2009.06.022
7. Hornbeck, P. V.; Kornhauser, J. M.; Tkachev, S.; Zhang, B.; Skrzypek, E.; Murray, B.; Latham, V.; Sullivan, M. PhosphoSitePlus: A Comprehensive Resource for Investigating the Structure and Function of Experimentally Determined Post-Translational Modifications in Man and Mouse Nucleic Acids Res. 2012, 40, D261 10.1093/nar/gkr1122
8. Diella, F.; Cameron, S.; Gemünd, C.; Linding, R.; Via, A.; Kuster, B.; Sicheritz-Pontén, T.; Blom, N.; Gibson, T. J. Phospho.ELM: A Database of Experimentally Verified Phosphorylation Sites in Eukaryotic Proteins BMC Bioinf. 2004, 5, 79 10.1186/1471-2105-5-79
9. Gnad, F.; Gunawardena, J.; Mann, M. PHOSIDA 2011: The Posttranslational Modification Database Nucleic Acids Res. 2011, 39, D253 10.1093/nar/gkq1159
10. Zhang, M.; Li, H.; He, Y.; Sun, H.; Xia, L.; Wang, L.-S.; Sun, B.; Ma, L.; Zhang, G.; Li, J.; Li, Y.-X.; Xie, L. Construction and Deciphering of Human Phosphorylation-Mediated Signaling Transduction Networks J. Proteome Res. 2015, 14, 150526033635001 10.1021/acs.jproteome.5b00249
11. Wu, R.; Dephoure, N.; Haas, W.; Huttlin, E. L.; Zhai, B.; Sowa, M. E.; Gygi, S. P. Correct Interpretation of Comprehensive Phosphorylation Dynamics Requires Normalization by Protein Expression Changes Mol. Cell. Proteomics 2011, 10 (8) M111.009654 10.1074/mcp.M111.009654
12. Franceschini, A.; Szklarczyk, D.; Frankild, S.; Kuhn, M.; Simonovic, M.; Roth, A.; Lin, J.; Minguez, P.; Bork, P.; Von Mering, C.; Jensen, L. J. STRING v9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration Nucleic Acids Res. 2013, 41, D808 10.1093/nar/gks1094
13. Chatr-Aryamontri, A.; Breitkreutz, B. J.; Heinicke, S.; Boucher, L.; Winter, A.; Stark, C.; Nixon, J.; Ramage, L.; Kolas, N.; O'Donnell, L.; Reguly, T.; Breitkreutz, A.; Sellam, A.; Chen, D.; Chang, C.; Rust, J.; Livstone, M.; Oughtred, R.; Dolinski, K.; Tyers, M. The BioGRID Interaction Database: 2013 Update Nucleic Acids Res. 2013, 41, D816 10.1093/nar/gks1158
14. Van Iersel, M. P.; Kelder, T.; Pico, A. R.; Hanspers, K.; Coort, S.; Conklin, B. R.; Evelo, C. Presenting and Exploring Biological Pathways with PathVisio BMC Bioinf. 2008, 9, 399 10.1186/1471-2105-9-399
15. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks Genome Res. 2003, 13, 2498-2504 10.1101/gr.1239303
16. Lotia, S.; Montojo, J.; Dong, Y.; Bader, G. D.; Pico, A. R. Cytoscape App Store Bioinformatics 2013, 29, 1350-1351 10.1093/bioinformatics/btt138
17. Jang, S.; Atkins, M. B. Which Drug, And When, For Patients with BRAF-Mutant Melanoma? Lancet Oncol. 2013, 14, e60-e69 10.1016/S1470-2045(12)70539-9
18. Flaherty, K. T.; Puzanov, I.; Kim, K. B.; Ribas, A.; McArthur, G. A.; Sosman, J. A.; O'Dwyer, P. J.; Lee, R. J.; Grippo, J. F.; Nolop, K.; Chapman, P. B. N. Engl. J. Med. 2010, 363, 809-819 10.1056/NEJMoa1002011
19. Kefford, R.; Arkenau, H.; Brown, M. P.; Millward, M.; Infante, J. R.; Long, G. V.; Ouellet, D.; Curtis, M.; Lebowitz, P. F. Phase I/II Study of GSK2118436, A Selective Inhibitor of Oncogenic Mutant BRAF Kinase, in Patients with Metastatic Melanoma and Other Solid Tumors J. Clin. Oncol. 2010, 28, 15s (suppl; abstr 8503)
20. Wagle, N.; Emery, C.; Berger, M. F.; Davis, M. J.; Sawyer, A.; Pochanard, P.; Kehoe, S. M.; Johannessen, C. M.; MacConaill, L. E.; Hahn, W. C.; Meyerson, M.; Garraway, L. A. Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling J. Clin. Oncol. 2011, 29, 3085-3096 10.1200/JCO.2010.33.2312
21. Chapman, P. B.; Hauschild, A.; Robert, C.; Haanen, J. B.; Ascierto, P.; Larkin, J.; Dummer, R.; Garbe, C.; Testori, A.; Maio, M.; Hogg, D.; Lorigan, P.; Lebbe, C.; Jouary, T.; Schadendorf, D.; Ribas, A.; O'Day, S. J.; Sosman, J. A.; Kirkwood, J. M.; Eggermont, A. M. M.; Dreno, B.; Nolop, K.; Li, J.; Nelson, B.; Hou, J.; Lee, R. J.; Flaherty, K. T.; McArthur, G. A. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation N. Engl. J. Med. 2011, 364, 2507-2516 10.1056/NEJMoa1103782
22. Flaherty, K. T.; Robert, C.; Hersey, P.; Nathan, P.; Garbe, C.; Milhem, M.; Demidov, L. V.; Hassel, J. C.; Rutkowski, P.; Mohr, P.; Dummer, R.; Trefzer, U.; Larkin, J. M. G.; Utikal, J.; Dreno, B.; Nyakas, M.; Middleton, M. R.; Becker, J. C.; Casey, M.; Sherman, L. J.; Wu, F. S.; Ouellet, D.; Martin, A.-M.; Patel, K.; Schadendorf, D. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma N. Engl. J. Med. 2012, 367, 107-114 10.1056/NEJMoa1203421
23. Smit, M. A.; Maddalo, G.; Greig, K.; Raaijmakers, L. M.; Possik, P. A.; van Breukelen, B.; Cappadona, S.; Heck, A. J. R.; Altelaar, A. F. M.; Peeper, D. S. Mol. Syst. Biol. 2014, 10, 772 10.15252/msb.20145450
24. Gillet, J.-P.; Varma, S.; Gottesman, M. M. The Clinical Relevance of Cancer Cell Lines J. Natl. Cancer Inst. 2013, 105, 452-458 10.1093/jnci/djt007
25. Boersema, P. J.; Raijmakers, R.; Lemeer, S.; Mohammed, S.; Heck, A. J. R. Multiplex Peptide Stable Isotope Dimethyl Labeling for Quantitative Proteomics Nat. Protoc. 2009, 4, 484-494 10.1038/nprot.2009.21
26. Zhou, H.; Low, T. Y.; Hennrich, M. L.; van der Toorn, H.; Schwend, T.; Zou, H.; Mohammed, S.; Heck, A. J. R. Enhancing the Identification of Phosphopeptides from Putative Basophilic Kinase Substrates Using Ti (IV) Based IMAC Enrichment Mol. Cell. Proteomics 2011, 10, M110.006452-M110.006452 10.1074/mcp.M110.006452
27. Frese, C. K.; Altelaar, A. F. M.; Hennrich, M. L.; Nolting, D.; Zeller, M.; Griep-Raming, J.; Heck, A. J. R.; Mohammed, S. Improved Peptide Identification by Targeted Fragmentation Using CID, HCD and ETD on an LTQ-Orbitrap Velos J. Proteome Res. 2011, 10, 2377-2388 10.1021/pr1011729
28. Cox, J.; Mann, M. MaxQuant Enables High Peptide Identification Rates, Individualized P.p.b.-Range Mass Accuracies and Proteome-Wide Protein Quantification Nat. Biotechnol. 2008, 26, 1367-1372 10.1038/nbt.1511
29. Kelder, T.; Van Iersel, M. P.; Hanspers, K.; Kutmon, M.; Conklin, B. R.; Evelo, C. T.; Pico, A. R. WikiPathways: Building Research Communities on Biological Pathways Nucleic Acids Res. 2012, 40, D1301-D1307 10.1093/nar/gkr1074
30. Routledge, R. Fisher's Exact Test Encyclopedia of Biostatistics 2005, 1961-1964 10.1002/0470011815.b2a10020
31. Benjamini, Y.; Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing J. R. Stat. Soc. Ser. B 1995, 57, 289-300
32. Molhoek, K. R.; Shada, A. L.; Smolkin, M.; Chowbina, S.; Papin, J.; Brautigan, D. L.; Slingluff, C. L. Comprehensive Analysis of Receptor Tyrosine Kinase Activation in Human Melanomas Reveals Autocrine Signaling through IGF-1R Melanoma Res. 2011, 21 (4) 274-284 10.1097/CMR.0b013e328343a1d6
33. King, C. C.; Gardiner, E. M. M.; Zenke, F. T.; Bohl, B. P.; Newton, A. C.; Hemmings, B. A.; Bokoch, G. M. p21-Activated Kinase (PAK1) Is Phosphorylated and Activated by 3-Phosphoinositide-Dependent Kinase-1 (PDK1) J. Biol. Chem. 2000, 275, 41201-41209 10.1074/jbc.M006553200
34. Ahn, S. J.; Chung, K. W.; Lee, R. A.; Park, I. A.; Lee, S. H.; Park, D. E.; Noh, D. Y. Overexpression of betaPix-a in Human Breast Cancer Tissues Cancer Lett. 2003, 193, 99-107 10.1016/S0304-3835(03)00004-1
35. Bae, J.-Y.; Ahn, S.-J.; Lee, J. E.; Kim, J.-E.; Han, M.-R.; Han, W.; Kim, S. W.; Shin, H. J.; Lee, S. J.; Park, D.; Noh, D.-Y. BetaPix-a Enhances the Activity of Phospholipase Cgamma1 by Binding SH3 Domain in Breast Cancer J. Cell. Biochem. 2005, 94, 1010-1016 10.1002/jcb.20357
36. Van Aelst, L.; D'Souza-Schorey, C. Rho GTPases and Signaling Networks Genes Dev. 1997, 11, 2295-2322 10.1101/gad.11.18.2295
37. Chen, J.; Abi-Daoud, M.; Wang, A.; Yang, X.; Zhang, X.; Feilotter, H. E.; Tron, V. A. Stathmin 1 Is a Potential Novel Oncogene in Melanoma Oncogene 2013, 32, 1330-1337 10.1038/onc.2012.141
38. Whittaker, S. R.; Theurillat, J. P.; Van Allen, E.; Wagle, N.; Hsiao, J.; Cowley, G. S.; Schadendorf, D.; Root, D. E.; Garraway, L. A. A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition Cancer Discovery 2013, 3, 350-362 10.1158/2159-8290.CD-12-0470
39. Maertens, O.; Johnson, B.; Hollstein, P.; Frederick, D. T.; Cooper, Z. A.; Messiaen, L.; Bronson, R. T.; McMahon, M.; Granter, S.; Flaherty, K.; Wargo, J. A.; Marais, R.; Cichowski, K. Elucidating Distinct Roles for NF1 in Melanomagenesis Cancer Discovery 2013, 3, 338-349 10.1158/2159-8290.CD-12-0313
40. Gibney, G. T.; Smalley, K. S. M. An Unholy Alliance: Cooperation between BRAF and NF1 in Melanoma Development and BRAF Inhibitor Resistance Cancer Discovery 2013, 3, 260-263 10.1158/2159-8290.CD-13-0017
41. Dougherty, M. K.; Müller, J.; Ritt, D. A.; Zhou, M.; Zhou, X. Z.; Copeland, T. D.; Conrads, T. P.; Veenstra, T. D.; Lu, K. P.; Morrison, D. K. Regulation of Raf-1 by Direct Feedback Phosphorylation Mol. Cell 2005, 17, 215-224 10.1016/j.molcel.2004.11.055
42. Chakraborty, R.; Wieland, C. N.; Comfere, N. I. Molecular Targeted Therapies in Metastatic Melanoma Pharmacogenomics Pers. Med. 2013, 49-56 10.2147/PGPM.S44800
43. Roux, P. P.; Shahbazian, D.; Vu, H.; Holz, M. K.; Cohen, M. S.; Taunton, J.; Sonenberg, N.; Blenis, J. RAS/ERK Signaling Promotes Site-Specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-Dependent Translation J. Biol. Chem. 2007, 282, 14056-14064 10.1074/jbc.M700906200
44. Lescarbeau, R. M.; Kaplan, D. L. Quantitative Analysis of Castration Resistant Prostate Cancer Progression through Phosphoproteome Signaling BMC Cancer 2014, 14, 325 10.1186/1471-2407-14-325
45. Fang, D.; Hawke, D.; Zheng, Y.; Xia, Y.; Meisenhelder, J.; Nika, H.; Mills, G. B.; Kobayashi, R.; Hunter, T.; Lu, Z. Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity J. Biol. Chem. 2007, 282 (15) 11221-11229 10.1074/jbc.M611871200
46. Van Der Velden, J. L. J.; Guala, A. S.; Leggett, S. E.; Sluimer, J.; Badura, E. C. H. L.; Janssen-Heininger, Y. M. W. Induction of a Mesenchymal Expression Program in Lung Epithelial Cells by Wingless Protein (Wnt)/β-Catenin Requires the Presence of c-Jun N-Terminal Kinase-1 (JNK1) Am. J. Respir. Cell Mol. Biol. 2012, 47 (3) 306-314 10.1165/rcmb.2011-0297OC
47. Adachi, M.; Zhang, Y.-B.; Imai, K. Mutation of BAD within the BH3 Domain Impairs Its Phosphorylation-Mediated Regulation FEBS Lett. 2003, 551 (1-3) 147-152 10.1016/S0014-5793(03)00915-3